BD (NYSE:BDX) announced today that it named its Diabetes Care business — which it plans to spin off next year — “embecta.”
Franklin Lakes, New Jersey-based BD confirmed in May that it plans to spin off its Diabetes Care business as an independent, publicly-traded company during the first half of 2022 and confirmed today that it expects that spinoff to close in the second quarter of the 2022 calendar year.
Get the full story at our sister site, Drug Delivery Business News.